617 followers
Article: Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer - Journal of Hematology & Oncology https://t.co/WpnRV4fyBk
Article: Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer - Journal of Hematology & Oncology https://t.co/WpnRV4fyBk
RT @GlopesMd: New study out: Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer https://t.co/40Qw4aegcy
New study out: Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer https://t.co/40Qw4aegcy
Study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer. #Oncology https://t.co/6g5S8bkub2